TO TERMINATE A PREGNANCY OF 49 DAYS OR LESS DURATION:
ADULTS-600 MILLIGRAMS (MG) (THREE 200 MG TABLETS) AS A SINGLE ORAL DOSE FOLLOWED TWO DAYS LATER BY 400 MICROGRAMS (MCG) (TWO 200 MCG TABLETS) OF MISOPROSTOL AS A SINGLE ORAL DOSE.
MEDICAL TERMINATION OF INTRA-UTERINE PREGNANCY OF UP TO 63 DAYS GESTATION, BY MOUTH, MIFEPRISTONE 600 MG (200 MG MAY BE EFFECTIVE) AS A SINGLE DOSE UNDER MEDICAL SUPERVISION, FOLLOWED 36 - 48 HOURS LATER (UNLESS ABORTION ALREADY COMPLETE) BY GEMEPROST 1 MG BY VAGINA AND OBSERVED FOR AT LEAST 3 HOURS (OR UNTIL BLEEDING OR PAIN AT ACCEPTABLE LEVEL); FOLLOW-UP VISIT 10 - 14 DAYS LATER TO VERIFY COMPLETE EXPULSION (IF TREATMENT FAILS ESSENTIAL THAT PREGNANCY BE TERMINATED BY ANOTHER METHOD)
CERVICAL RIPENING BEFORE MECHANICAL CERVICAL DILATATION FOR TERMINATION OF PREGNANCY, 36 - 48 HOURS BEFORE PROCEDURE, BY MOUTH, MIFEPRISTONE 600 MG AS A SINGLE DOSE UNDER MEDICAL SUPERVISION
TERMINATION OF PREGNANCY OF 13 - 24 WEEKS GESTATION (IN COMBINATION WITH GEMEPROST), BY MOUTH, MIFEPRISTONE 600 MG (200 MG MAY BE EFFECTIVE) AS A SINGLE DOSE UNDER MEDICAL SUPERVISION FOLLOWED 36 - 48 HOURS LATER BY GEMEPROST 1 MG BY VAGINA EVERY 3 HOURS UP TO MAX. 5 MG; IF ABORTION DOES NOT OCCUR, 24 HOURS AFTER START OF TREATMENT REPEAT COURSE OF GEMEPROST 1 MG BY VAGINA UP TO MAX. 5 MG (IF TREATMENT FAILS PREGNANCY SHOULD BE TERMINATED BY ANOTHER METHOD); FOLLOW-UP VISIT AFTER APPROPRIATE INTERVAL TO ASSESS VAGINAL BLEEDING RECOMMENDED
NOTE CAREFUL MONITORING OF BLOOD PRESSURE AND PULSE ESSENTIAL FOR 3 HOURS AFTER ADMINISTRATION OF GEMEPROST PESSARY (RISK OF PROFOUND HYPOTENSION)
LABOUR INDUCTION IN FETAL DEATH IN UTERO, BY MOUTH, MIFEPRISTONE 600 MG DAILY AS A SINGLE DOSE FOR 2 DAYS UNDER MEDICAL SUPERVISION; IF LABOUR NOT STARTED WITHIN 72 HOURS OF FIRST DOSE, ANOTHER METHOD SHOULD BE USED